Tiziana Life Sciences CEO reports share holdings
Tiziana Life Sciences Ltd director and chief executive officer Ivor Elrifi filed an initial statement of beneficial ownership.
Rhea-AI Filing Summary
Tiziana Life Sciences Ltd director and chief executive officer Ivor Elrifi filed an initial statement of beneficial ownership. He reports direct ownership of 3,805,261 shares of common stock and restricted stock units linked to 3,150,000 underlying common shares.
These restricted stock units are reported with a conversion or exercise price of $1.26 per share, first exercisable on 2026-08-15 and expiring on 2028-08-15. Remarks state that 1,050,000 RSUs will vest annually over three years.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Elrifi Ivor
Role
CHIEF EXECUTIVE OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | COMMON STOCK | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 3,150,000 contracts (Direct);
COMMON STOCK — 3,805,261 shares (Direct)
Key Figures
Common stock holdings: 3,805,261 shares
RSU underlying shares: 3,150,000 shares
RSU vesting per year: 1,050,000 RSUs
+3 more
6 metrics
Common stock holdings
3,805,261 shares
Direct common stock held by Ivor Elrifi following the reported holdings
RSU underlying shares
3,150,000 shares
Underlying common shares linked to restricted stock units held directly
RSU vesting per year
1,050,000 RSUs
Number of RSUs scheduled to vest annually over three years
RSU exercise price
$1.2600 per share
Conversion or exercise price for the restricted stock units
RSU first exercisable date
2026-08-15
Date from which the restricted stock units become exercisable
RSU expiration date
2028-08-15
Expiration date for the restricted stock units
Key Terms
Restricted Stock Unit, underlying security shares, exercise price
3 terms
Restricted Stock Unit financial
"security_title "Restricted Stock Unit" with underlying common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
exercise price financial
"conversion_or_exercise_price reported as 1.2600 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many RSUs does TLSA CEO Ivor Elrifi hold, and how will they vest?
Ivor Elrifi holds restricted stock units linked to 3,150,000 underlying common shares. According to the remarks, 1,050,000 RSUs will vest each year over three years, indicating an annual vesting schedule across that three-year period.
What are the key terms of Ivor Elrifi's RSUs at Tiziana Life Sciences (TLSA)?
Elrifi’s restricted stock units are reported with a $1.26 conversion or exercise price per share, first exercisable on 2026-08-15 and expiring on 2028-08-15. They relate to 3,150,000 underlying common shares held directly.
Is Ivor Elrifi both a director and an officer of Tiziana Life Sciences (TLSA)?
Yes. The filing identifies Ivor Elrifi as both a director and an officer of Tiziana Life Sciences, with the officer title of Chief Executive Officer. This dual role is disclosed alongside his reported common stock and restricted stock unit holdings.
Does the Tiziana Life Sciences (TLSA) Form 3 show any recent stock purchases or sales?
The Form 3 presents holdings rather than new transactions, listing Elrifi’s common stock and RSU positions. Transaction data show no coded buy or sell entries, indicating the document serves as an initial ownership snapshot rather than a trade report.
AI-generated analysis. How Rhea-AI works. Not financial advice.
